Dicamba and 2,4-D in the Urine of Pregnant Women in the Midwest: Comparison of Two Cohorts (2010–2012 vs. 2020–2022) Abstract Currently, there are no known human biomonitoring studies that concurrently examine biomarkers of dicamba and 2,4-D. We sought to compare…
A methods paper is about our flagship study is being published in Chemosphere, a peer-reviewed scientific journal published since 1972 by Elsevier. It publishes both original research and review articles in environmental chemistry. We extend our thanks to the authors:…
As 2022 comes to a close, HHRA is happy to report progress on all fronts. We share some highlights from 2022 and describe what we hope to accomplish in 2023-2025. A NEW MISSION AND VISION As a part of our…
On November 8th, HHRA-sponsored a 90-minute special session on “Herbicides and Birth Outcomes” at the annual meeting of the American Public Health Association (APHA) in Boston. Our session was among a very few exploring how food and farming systems impact…
HHRA's team has been making lots of progress in our important work at the intersection of food, farming, and health. We started the spring/summer of with a bang as we brought HHRA on the road to the Public Health Conference…
Reporter Emily Unglesbee with DTN/Progressive Farmer has done solid reporting for years now on the trials and tribulations of dicamba herbicide and the XtendiMax GMO soybean and cotton seeds it has been applied on since 2016. Dicamba is one of…
HHRA is pleased to announce a new partnership with the Centre de toxicologie du Québec analytical laboratory, or CTQ. This world-renowned lab will process biological samples collected through HHRA's medical research on the public health implications of pesticide exposure. For…